Reports
Global Biomaterials Market Size, Share, Growth, Value, Report: By Product: Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial; By Application: Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Dental, Plastic Surgery, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2023-2031
Global Biomaterials Market Outlook
The global biomaterial market size attained a value of USD 130.8 billion in 2022. The market is likely to grow further at a CAGR of 14.10% during the forecast period of 2023-2031 to attain a value of USD 429.9 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Orthopaedics Segment to Augment the Growth of the Global Biomaterials Industry
Based on application, the orthopaedics segment is expected to hold a significant share in the global biomaterials industry during the forecast period. This growth can be attributed to the increasing demand for orthopaedic implant surgery as a result of the rising prevalence of orthopaedic disorders, which, in turn, is enhancing the demand for metallic biomaterials for surgical procedures owing to their excellent load-bearing properties. In addition, the increasing investments to develop improved products are also aiding the market. For instance, researchers at the University of Birmingham have created a new thermoplastic biomaterial from a type of nylon. This biomaterial can be shaped using heat and is strong enough to be used as a bone implant. Such developments are expected to drive the market growth in the coming years.
North America to Occupy a Significant Market Share in the Global Biomaterials Industry
North America is predicted to hold a significant market share in the global biomaterials industry. This surge can be attributed to the favourable initiatives taken by the leading manufacturers and the government in the region to expand the usage of biomaterials in a variety of clinical applications. In addition, the growing geriatric population, which is more susceptible to illnesses and injury, is leading to an increased demand for biomaterials in applications such as cardiovascular and dental implants. For instance, in 2019, the leading biomaterial manufacturer, Zimmer Biomet Holdings Inc, announced the FDA clearance for its new Persona Revision Knee System for the revision knee replacement procedures.
Biomaterials: Market Segmentation
Biomaterials refer to a substance that is created to interact with biological systems for clinical purposes, which can be therapeutic in order to treat and repair a tissue function of the body or diagnostic. These can be derived from nature or constructed in a lab setting by utilising chemical solutions to use metallic components, polymers, ceramics or composite materials. These are used in biomedical devices that are used to augment or replace a natural body function, such as heart valves or hip implants and are very commonly used in dental applications. Materials such as certain types of metals, ceramics, plastic, glass, and even living cells and tissue can be utilised in the process of creating biomaterials.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product type, the market is distributed into:
- Natural Biomaterial
- Metallic Biomaterial
- Ceramic Biomaterial
- Polymeric Biomaterial
On the basis of application, the industry can be categorised into:
- Neurology
- Cardiology
- Orthopaedics
- Ophthalmology
- Wound Care
- Dental
- Plastic Surgery
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Rapid Technological Advancements to Bolster the Growth of the Global Biomaterials Industry
Biomaterials are increasingly being developed to provide effective treatment and replacement facilities among patients. Through the use of advanced technological solutions, the leading manufacturers are creating biomaterials that are versatile and can be utilised in varied clinical procedures such as tissue engineering. Moreover, the development of smart biomaterials that have the ability to interact with biological systems and to respond to changes in physiological parameters and external stimuli is also expected to contribute to the market growth. In addition, the rising investments in the expansion of the healthcare infrastructure due to the growing prevalence of chronic illnesses and the rapidly ageing population are also expected to positively impact the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Global Biomaterials Market
The report gives a detailed analysis of the following key players in the global biomaterials market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Koninklijke DSM N.V.
- Corbion N.V.
- Zimmer Biomet
- Noble Biomaterials Inc.
- Bayer AG
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biomaterial Market Overview
3.1 Global Biomaterial Market Historical Value (2016-2022)
3.2 Global Biomaterial Market Forecast Value (2023-2031)
4 Global Biomaterial Market Landscape
4.1 Global Biomaterial Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biomaterial Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Region
4.2.3 Analysis by Applications
5 Global Biomaterial Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biomaterial Market Segmentation
6.1 Global Biomaterial Market by Product
6.1.1 Market Overview
6.1.2 Natural Biomaterial
6.1.3 Metallic Biomaterial
6.1.4 Ceramic Biomaterial
6.1.5 Polymeric Biomaterial
6.2 Global Biomaterial Market by Application
6.2.1 Market Overview
6.2.2 Neurology
6.2.2.1 Neural stem cell encapsulation
6.2.2.2 Shunting systems
6.2.2.3 Hydrogel scaffold
6.2.2.4 Cortical neural prosthetics
6.2.2.5 Others
6.2.3 Cardiology
6.2.3.1 Sensors
6.2.3.2 Stents
6.2.3.3 Implantable Cardiac defibrillators
6.2.3.4 Pacemakers
6.2.3.5 Vascular graft Market
6.2.3.6 Others
6.2.4 Orthopedics
6.2.4.1 Joint Replacement Biomaterials
6.2.4.2 Orthobiologics
6.2.4.3 Bio-resorbable tissue fixation products
6.2.4.4 Viscosupplementation
6.2.4.5 Spine Biomaterials
6.2.4.6 Others
6.2.5 Ophthalmology
6.2.5.1 Synthetic Corneas
6.2.5.2 Intraocular Lens Market
6.2.5.3 Contact Lens
6.2.5.4 Ocular tissue replacement
6.2.5.5 Others
6.2.6 Wound Care
6.2.6.1 Fracture Healing Device
6.2.6.2 Adhesion Barrier
6.2.6.3 Skin Substitute
6.2.6.4 Internal Tissue Sealant
6.2.6.5 Surgical Hemostats
6.2.6.6 Others
6.2.7 Dental
6.2.7.1 Tissue Regeneration Material
6.2.7.2 Dental Implants
6.2.7.3 Bone Grafts and Substitutes
6.2.7.4 Dental Membranes
6.2.7.5 Others
6.2.8 Plastic Surgery
6.2.8.1 Facial Wrinkle Treatment
6.2.8.2 Soft Tissue Fillers
6.2.8.3 Craniofacial Surgery
6.2.8.4 Bioengineered skins
6.2.8.5 Peripheral nerve repair
6.2.8.6 Acellular dermal matrices
6.2.8.7 Others
6.2.9 Others
6.3 Global Biomaterial Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Biomaterial Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biomaterial Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biomaterial Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biomaterial Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biomaterial Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Koninklijke DSM N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Corbion N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Zimmer Biomet
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Noble Biomaterials Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bayer AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Berkeley Advanced Biomaterials
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Evonik Industries AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 CAM Bioceramics B.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Carpenter Technology Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Grifols, S.A.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Invibio Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BASF SE
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Zimmer Biomet Holdings, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Pfizer Inc, Alkermes
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Covalon Technologies Ltd.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Collagen Matrix, Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Corbion
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Biomaterial Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The biomaterial Market was valued at USD 130.8 billion in 2022.
The market is expected to grow at a CAGR of 14.10% from 2023 to 2031 to reach a value of USD 429.9 billion by 2031.
The major drivers of the industry, such as the increased demand for biomaterials in a variety of medical applications, the rising concerns of cardiovascular diseases, the rapidly growing geriatric population, and multifaceted application possibilities of biomaterial technology, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the rapid technological advancements and the heightened investments in the R&D of biomaterials technology.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product types available in the market are natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial.
The significant applications of the product include neurology, cardiology, orthopaedics, ophthalmology, wound care, dental, and plastic surgery, among others.
The major players in the industry are Koninklijke DSM N.V., Corbion N.V., Zimmer Biomet, Noble Biomaterials Inc., Bayer AG, and others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER